Veterinary Medicines

VIRBACTAN 150 MG INTRAMAMMARY OINTMENT

Authorised
  • Cefquinome sulfate
Download as PDF

Product identification

Medicine name:
VIRBACTAN 150 MG INTRAMAMMARY OINTMENT
Virbactan 50 mg/g Pommade intramammaire
Active substance:
  • Cefquinome sulfate
Target species:
  • Cattle (cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefquinome sulfate
    177.80
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (cow)
      • Meat and offal
        2
        day
      • Milk
        36
        day
      • Milk
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51DE90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • HAUPT PHARMA LATINA
  • Virbac
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • V859/05/02/2000
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0148/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Estonia
  • Germany
  • Greece
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 20/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."